CClinicalTrials.gg
RecruitingNCT07217262PCOCUpdated Feb 10, 2026

Proactive Costs of Care Study

An interventional study of Educational Intervention in Financial Burden, Financial Toxicity and Financial Stress, sponsored by Cedars-Sinai Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-10.

Sponsored by Cedars-Sinai Medical Center · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Dec 2025; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The Proactive Costs of Care intervention is an educational intervention designed to help patients deal with the cost of cancer care. The main goal of this trial is to evaluate whether the Proactive Costs of Care intervention can be successfully delivered to cancer patients who are starting a new treatment and their caregivers by looking at how many participants complete the intervention. The other questions the trial aims to answer are whether the intervention can:

  • Improve confidence in solving problems related to costs of care
  • Reduce distress related to finances

Participants will complete the Proactive Costs of Care intervention, which is an approximately 30-minute one-time session with a lay educator reviewing the Proactive Costs of Care Guide and Cost Tracker. The intervention can be completed in person, by video, and by phone. Participants will also complete two surveys- one to be completed before the intervention and one to be completed 3 months after the intervention.

Read the detailed description

The Proactive Costs of Care (PCOC) study aims to assess whether the Proactive Costs of Care intervention can be successfully delivered to cancer patients or their caregivers and help them deal with the costs of cancer care. Patients who are over 18 years of age or older, diagnosed with gynecologic cancer (e.g. endometrial/uterine, cervical, ovarian, vulvar cancers), on active systemic therapy within 30 days of enrollment, receiving treatment at Cedars-Sinai Medical Center, and can speak, read, and understand English are eligible to participate. Caregivers of patients who meet the eligibility criteria above are also eligible to participate.

The Proactive Costs of Care Guide and Cost Tracker were developed with the input of patients, caregivers, social workers, nurses, doctors, and other healthcare workers to address financial burden due to the cost of cancer care. The Proactive Costs of Care Guide covers 3 main topics; health insurance, employment, and personal and community support. The Proactive Costs of Care Cost Tracker helps patients or their caregivers track their medical costs. All of the materials are available in a paper version or electronic version.

Participants will complete a baseline survey before the intervention and a follow-up survey 3 months after the intervention. The patient survey will collect demographic information and ask questions about confidence in solving problems, health insurance literacy, financial distress or well-being, and emotional well-being. The caregiver survey will collect demographic information, confidence in solving problems, health insurance literacy, financial distress or well-being, and caregiver strain.

02

Conditions studied

  • Financial Burden
  • Financial Toxicity
  • Financial Stress
  • Financial Navigation
  • Gynecologic Cancers
  • Caregiver Burnout

Keywords

  • Financial Navigation
  • Financial Toxicity
  • Financial Distress
  • Financial Burden
  • Gynecologic Cancers
  • Caregiver Burnout
03

In context

Financial Stress

93 studies on the registry are indexed under Financial Stress; 32 are open to participants now.

This study's planned enrollment of 36 is below the median of 124 across 55 interventional studies indexed under Financial Stress.

Browse Financial Stress studies →

Lead sponsor

Cedars-Sinai Medical Center is the lead sponsor of 441 studies on the registry; 108 are open to participants now.

Of its 62 completed or terminated interventional studies of FDA-regulated products, 47 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for Patient Participants:

  • Individuals 18 years old or older are included.
  • Individuals diagnosed with gynecologic cancer
  • On active systemic therapy within 30 days of enrollment
  • Receiving treatment at Cedars-Sinai Medical Center
  • Can speak, read, and understand English

Inclusion Criteria for Caregiver Participants:

- Caregivers to patients who satisfy the criteria above

Exclusion Criteria for Patient and Caregiver Participants:

  • Any patients whose records are flagged "break the glass" or "research opt out."
  • Cannot speak, read, or understand English
  • Not willing to participate in the intervention or complete surveys
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Patient and Caregiver Arm of Proactive Costs of Care Study

    No comparator group

    Behavioral: Educational Intervention

Interventions

  • BehavioralEducational Intervention

    Participants will receive the Proactive Costs of Care Guide that covers health insurance, employment, and finding personal and community support. They will also receive the Proactive Costs of Care Cost Tracker to help track medical costs. This one-time intervention can be completed in-person, by video, or by phone. A trained lay educator will spend approximately 30 minutes reviewing health insurance and discussing the 2-3 topics most relevant to the participant. All of the materials are available in a paper version or electronic version.

06

What researchers measure

Primary outcomes

  1. Participant Completion Rate of Educational Intervention

    The number of participants who completed the intervention divided by the total number of participants who consented to the study

    Time frame: From enrollment to 2 months

Secondary outcomes

  1. Change in Self-Efficacy using PROMIS Self-Efficacy

    Scores range from 10-50, with higher scores indicating more self-efficacy

    Time frame: From intervention to 3 months

  2. Change in financial distress using InCharge Financial Distress/Financial Well-Being Scale

    Scores range from 1-10, with higher scores indicating less financial distress

    Time frame: From intervention to 3 months

07

Study locations

1 of 1 sites recruiting
  • Cedars-Sinai Medical Center
    Los Angeles, California 90048, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07217262
Lead sponsor
Cedars-Sinai Medical Center
Collaborators
Merck Sharp & Dohme LLC, Foundation for Women's Cancers
Responsible party
Margaret Liang (Principal Investigator, Staff Physician OBGYN, Cedars-Sinai Medical Center) — Principal investigator
First posted
Oct 15, 2025
Start date
Dec 22, 2025
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Feb 10, 2026

Study contacts

Shu-Fan Chen, BS
Contact
Shu-Fan.Chen@cshs.org
(323) 413-7804
Margaret Liang, MD, MS
principal investigator · Cedars-Sinai Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion